Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Apr 15;332(7546):890-4.
doi: 10.1136/bmj.332.7546.890.

Systemic lupus erythematosus

David P D'Cruz  1
Affiliations
Review

Systemic lupus erythematosus

David P D'Cruz. BMJ. .
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig 1
33 year old woman with anti-Ro (SS-A) antibodies and subacute cutaneous lupus responding to combination therapy with mepacrine and methotrexate
Fig 2
Fig 2
Woman aged 43 years with a 20 year history of SLE, lupus nephritis, and antiphospholipid syndrome presenting with angina. Nuclear medicine Myoview scan shows reversible ischaemia with S-T changes on stress. Coronary angiography confirmed diffuse coronary artery disease
See this image and copyright information in PMC

References

    1. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995;38: 551-8. - PubMed
    1. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349: 1526-33. - PubMed
    1. Tench CM, McCarthy J, McCurdie I, White PD, D'Cruz DP. Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) 2003;42: 1050-4. - PubMed
    1. Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term follow-up of patients in the Euro-lupus nephritis trial. Arthritis Rheum 2004;50: 3934-40. - PubMed
    1. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353: 2219-28. - PubMed

MeSH terms

Substances